85 related articles for article (PubMed ID: 7855734)
1. 5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine.
Rasmusson AM; Goldstein LE; Deutch AY; Bunney BS; Roth RH
Synapse; 1994 Nov; 18(3):218-24. PubMed ID: 7855734
[TBL] [Abstract][Full Text] [Related]
2. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
3. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
4. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
Casanovas JM; Lésourd M; Artigas F
Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
[TBL] [Abstract][Full Text] [Related]
5. Selective 5-HT1A receptor agonist, 8-OH-DPAT, locally administered into the dorsal raphe nucleus increased extracellular acetylcholine concentrations in the medial prefrontal cortex of conscious rats.
Katsu H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Oct; 21(4):121-3. PubMed ID: 11769569
[TBL] [Abstract][Full Text] [Related]
6. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
7. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
8. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
[TBL] [Abstract][Full Text] [Related]
10. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
[TBL] [Abstract][Full Text] [Related]
11. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation.
Gogos A; Kusljic S; van den Buuse M
Pharmacol Biochem Behav; 2005 Jul; 81(3):664-72. PubMed ID: 15955549
[TBL] [Abstract][Full Text] [Related]
12. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z
Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046
[TBL] [Abstract][Full Text] [Related]
13. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
Scott PA; Chou JM; Tang H; Frazer A
J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
Misane I; Johansson C; Ogren SO
Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
17. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom.
Jang CG; Kang M; Cho JH; Lee SB; Kim H; Park S; Lee J; Park SK; Hong M; Shin MK; Shim IS; Bae H
Arch Pharm Res; 2004 Oct; 27(10):1065-72. PubMed ID: 15554266
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
20. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
